What is a stock summary page? Click here for an overview.
Business Description
Kadimastem Ltd
ISIN : IL0011284614
Description
Kadimastem Ltd is a biopharmaceutical company that develops industrial regenerative medicine therapies based on differentiated cells derived from Human Embryonic Stem Cells (hESCs) to treat neuro-degenerative diseases such as ALS and Diabetes. It is developing revolutionary regenerative therapies based on stem cells.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.28 | |||||
| Equity-to-Asset | -1.52 | |||||
| Debt-to-Equity | -0.9 | |||||
| Debt-to-EBITDA | -1.27 | |||||
| Piotroski F-Score | 1/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 44.3 | |||||
| 3-Year EPS without NRI Growth Rate | 42 | |||||
| 3-Year FCF Growth Rate | 43.5 | |||||
| 3-Year Book Growth Rate | 36.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 82.19 | |||||
| 9-Day RSI | 72.44 | |||||
| 14-Day RSI | 66.51 | |||||
| 3-1 Month Momentum % | 60.4 | |||||
| 6-1 Month Momentum % | 176.46 | |||||
| 12-1 Month Momentum % | 301.92 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.33 | |||||
| Quick Ratio | 0.33 | |||||
| Cash Ratio | 0.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -28.1 | |||||
| Shareholder Yield % | -0.26 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -124.6 | |||||
| ROIC % | -72.41 | |||||
| 3-Year ROIIC % | -95.99 | |||||
| ROC (Joel Greenblatt) % | -381.2 | |||||
| ROCE % | -1135.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -11.7 | |||||
| EV-to-EBITDA | -16 | |||||
| EV-to-FCF | -11.86 | |||||
| Earnings Yield (Greenblatt) % | -8.53 | |||||
| FCF Yield % | -7.87 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kadimastem Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₪) | |||
| EPS (TTM) (₪) | -1.329 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | 0.07 | ||
| 3-Year Sortino Ratio | 0.12 | ||
| Volatility % | 57.4 | ||
| 14-Day RSI | 66.51 | ||
| 14-Day ATR (₪) | 1.438526 | ||
| 20-Day SMA (₪) | 18.9835 | ||
| 12-1 Month Momentum % | 301.92 | ||
| 52-Week Range (₪) | 4.3 - 22.77 | ||
| Shares Outstanding (Mil) | 4.19 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kadimastem Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kadimastem Ltd Stock Events
| Event | Date | Price (₪) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kadimastem Ltd Frequently Asked Questions
What is Kadimastem Ltd(XTAE:KDST)'s stock price today?
The current price of XTAE:KDST is ₪20.92. The 52 week high of XTAE:KDST is ₪22.77 and 52 week low is ₪4.30.
When is next earnings date of Kadimastem Ltd(XTAE:KDST)?
The next earnings date of Kadimastem Ltd(XTAE:KDST) is .
Does Kadimastem Ltd(XTAE:KDST) pay dividends? If so, how much?
Kadimastem Ltd(XTAE:KDST) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers